Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Obstet Gynecol. 2018 Oct;132(4):843–849. doi: 10.1097/AOG.0000000000002870

Table 2.

Maternal characteristics as study enrollment by randomization group in stage 1 hypertensive women

Placebo Aspirin P value
n 98 66 NA
Age 22.4 ± 5.9 21.3 ± 4.8 0.3
Pre-pregnancy BMI 28.0 ± 7.4 27.3 ± 5.9 0.9
Race
 White,non-Hispanic
 African American
 Hispanic

26 (26.5)
52 (53.1)
20 (20.4)

15 (22.7)
40 (60.6)
11 (16.7)

0.6
Smoker at start of pregnancy 24 (24.5) 15 (22.7) 0.8
Gestational age at delivery (weeks) 38.6 ± 3.3 38.7 ± 4.1 0.1
Birth weight (grams) 3197 ± 674 3240 ± 691 0.4
Systolic blood pressure (mmHg)** 125 ± 8 122 ± 10 0.07
Diastolic blood pressure (mmHg)** 75 ± 7 77 ± 7 0.2
*

Stage 1 hypertension= systolic blood pressure 130-135 mmHg or diastolic 80-85 mmHg;

**

Measured at enrollment (13-25 weeks of pregnancy); BMI= body mass index

Data are presented as mean ± standard deviation or n (%)